(11/15/05) Early Stage Biotech Funding Strategies Conference ($40)

The Real Deal:
Funding Strategies for Early Stage Biotechnology Companies
TEMPLE UNIVERSITY COUNCIL FOR ENTREPRENEURSHIP


Life sciences researchers, biotechnology companies, and investors are encouraged to attend this one half day conference to better understand the funding environment for the biotechnology industry. The conference features a showcase of Temple University Centers, Institutes & services for Life Sciences & Biotechnology companies.

Tuesday, November 15, 2005

at the Desmond Hotel and Conference Center
One Liberty Boulevard, Malvern, PA

7:30AM Registration, breakfast & networking
8:30AM Conference begins
Conference concludes by 11:30 AM

$30 if registered and paid by November 7.

$40 if registrered by November 7 and paid at the door.

Free to current Temple students, staff and faculty with valid ID. Temple affiliates may call 215-204-3081 for transportation details.

Register Now!

Moderators
Manya Deehr, Esq., Morgan Lewis
Gerianne Tringali DiPiano, CEO, FemmePharma Global Healthcare


Panels

Venture Capital

What can both sides expect in a venture capital financing deal? What are some strategies to cope with demands for board and management control and equity control? When should you walk away from a round of financing?
Elaine Jones, General Partner, EuclidSR Partners
Ezra Felker, Entrepreneur In Residence, BioAdvance
Robert J. Towarnicki, President and CEO, Nucleonics, Inc.

Strategic Alliances

What are big pharmaceutical companies are looking for in a potential partner? How can early-stage companies stand out?
Herbert Ormsbee, Ph.D., Senior Director, Licensing and Business Development, Pfizer, Inc.
Mike Cola, Executive Vice President, Global Therapeutics Area Business Units, Shire Pharmaceuticals Group plc
Gerianne Tringali DiPiano, CEO, FemmePharma Global Healthcare


Investment Banks

What are the essential components needed for an IPO? The panel will present sample case studies of successful IPOs, along with failures.
Mike Mufson, Managing Director Info Tech and Merger & Acquisitions, Mufson, Howe, Hunter & Company LLC
Karen S. Batchelder, Managing Director – Group Head, Investment Banking, Legg Mason
Anthony Lopez-Ona, Director, Mufson Howe Hunter & Company LLC

Presented by
Temple University Council on Entrepreneurship
In Partnership with Temple University’s

Fox School of Business

School of Dentistry

College of Engineering

College of Health Professions School of Medicine

School of Pharmacy

College of Science & Technology
Office of the Vice President for Research & Graduate Studies
Sbarro Institute for Cancer Research and Molecular Medicine at Temple

And the
Innovation and Entrepreneurship Institute

Sponsors
Morgan Lewis & Bockius LLP

Sbarro Health Research Organization

Microsoft

WinfoSoft

PA Bio